This study aims to integrate existing evidence on these connections [17,18], hypothesizing that RA patients display elevated RANKL levels and that certain RANKL polymorphisms (rs9533156 and rs2277438) are linked with increased RA risk. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.